Hospitalization as an opportunity to optimize glycemic control in oncology patients Review
| Authors: | Hiestand, A.; Flory, J.; Chitkara, R. |
| Review Title: | Hospitalization as an opportunity to optimize glycemic control in oncology patients |
| Abstract: | Purpose of Review: Many patients experience hyperglycemia during cancer treatment, either as a new-onset condition or as an exacerbation of existing diabetes. This can impact treatment and outcomes, increasing the risk of complications and worsening health-related quality of life (HRQoL). These issues may be particularly significant when patients are hospitalized and/or acutely ill. The purpose of this review is to identify common barriers and strategies specific to the inpatient setting to improve glycemic control and minimize complications both while patients are hospitalized and after discharge. Recent Findings: Hyperglycemia in patients who are hospitalized during cancer treatment is common, but there is a lack of consensus on goals and approaches to glycemic management in this setting. Hyperglycemia related to oncology treatment can have unusual causes and challenges in management. Organizational guidelines can help standardize treatment and guide providers in managing hyperglycemia in oncology patients during hospitalization and upon discharge. Hospitalization is a critical period that provides an opportunity to reassess and modify management plans, coordinate follow-up care, and, crucially, educate and empower patients to successfully manage their blood glucose levels once they are discharged. Emerging technology such as patient portals can facilitate hyperglycemia management after discharge. Summary: This review discusses evidences and strategies to utilize the period of hospitalization to develop and implement an individualized plan of care for patients with concurrent hyperglycemia and cancer. © 2019, Springer Science+Business Media, LLC, part of Springer Nature. |
| Keywords: | prednisone; review; drug safety; treatment duration; cancer patient; pancreas cancer; follow up; quality of life; palliative therapy; patient education; dexamethasone; oncology; renal cell carcinoma; high risk patient; hodgkin disease; hyperglycemia; hospitalization; comorbidity; pancreatectomy; insulin; interpersonal communication; hospital discharge; antidiabetic agent; methylprednisolone; physical activity; terminal care; hydrocortisone; lifestyle modification; malnutrition; insulin dependent diabetes mellitus; transitional cell carcinoma; non insulin dependent diabetes mellitus; life expectancy; diabetes; personalized medicine; hospice care; self care; non small cell lung cancer; metastatic melanoma; cancer treatment; glycemic control; hemoglobin a1c; discharge; nivolumab; human; pembrolizumab; blood glucose monitoring; nutritional counseling; diabetes education; steroid-induced hyperglycemia |
| Journal Title: | Current Diabetes Reports |
| Volume: | 19 |
| Issue: | 12 |
| ISSN: | 1534-4827 |
| Publisher: | Springer |
| Date Published: | 2019-12-01 |
| Start Page: | 149 |
| Language: | English |
| DOI: | 10.1007/s11892-019-1283-6 |
| PUBMED: | 31776685 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Review -- Export Date: 2 January 2020 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work